GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BGM Group Ltd (NAS:BGM) » Definitions » Debt-to-EBITDA

BGM (BGM Group) Debt-to-EBITDA : 0.00 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is BGM Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

BGM Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.00 Mil. BGM Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.00 Mil. BGM Group's annualized EBITDA for the quarter that ended in Sep. 2024 was $1.93 Mil. BGM Group's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for BGM Group's Debt-to-EBITDA or its related term are showing as below:

BGM' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.45   Med: 0.59   Max: 2.05
Current: 0.12

During the past 8 years, the highest Debt-to-EBITDA Ratio of BGM Group was 2.05. The lowest was -0.45. And the median was 0.59.

BGM's Debt-to-EBITDA is ranked better than
87% of 677 companies
in the Drug Manufacturers industry
Industry Median: 1.62 vs BGM: 0.12

BGM Group Debt-to-EBITDA Historical Data

The historical data trend for BGM Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BGM Group Debt-to-EBITDA Chart

BGM Group Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Debt-to-EBITDA
Get a 7-Day Free Trial 1.05 1.93 0.47 -0.45 -

BGM Group Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.38 -0.13 -0.60 -

Competitive Comparison of BGM Group's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, BGM Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BGM Group's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BGM Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where BGM Group's Debt-to-EBITDA falls into.


;
;

BGM Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

BGM Group's Debt-to-EBITDA for the fiscal year that ended in Sep. 2024 is calculated as

BGM Group's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Sep. 2024) EBITDA data.


BGM Group  (NAS:BGM) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


BGM Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of BGM Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


BGM Group Business Description

Traded in Other Exchanges
N/A
Address
No. 152 Hongliang East 1st Street No. 1703, Tianfu New District, Chengdu, CHN, 610200
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.